Cytosorbents News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.02.22	First Patient Enrolled in the PROCYSS Multicenter Randomized Controlled Trial Evaluating CytoSorb® to Restore Hemodynamic Stability in Patients with Refractory Septic Shock (PR Newswire)
24.01.22	New Publication Reports Significant Reductions in Perioperative Bleeding Complications Following Acute Aortic Dissection Surgery using CytoSorbents' Antithrombotic Drug Removal Technology (PR Newswire)
18.01.22	CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue (PR Newswire)
21.12.21	CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as Vice President, Medical Affairs Cardiovascular (PR Newswire)
20.12.21	CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) (PR Newswire)
15.11.21	CytoSorbents to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and Jefferies London Healthcare Conference (PR Newswire)
04.11.21	CytoSorbents Reports Full Third Quarter 2021 Financial and Operational Results (PR Newswire)
20.10.21	CTSO : No Signal For Harm On CytoSorb Use In Patients Undergoing Surgery For Infective Endocarditis (RTTNews)
20.10.21	CytoSorbents Comments on REMOVE Study Presentation (PR Newswire)
14.10.21	First Patient Enrolled in U.S. STAR-T Pivotal Trial Evaluating the DrugSorb-ATR™ Antithrombotic Removal System to Remove Ticagrelor During Cardiothoracic Surgery (PR Newswire)
13.10.21	Pre-market Movers: WTRH, NEW, RGLS, KOSS, PROC… (RTTNews)
12.10.21	CytoSorbents Receives Full FDA Investigational Device Exemption (IDE) Approval to Begin U.S. STAR-D Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ Antithrombotic Removal System Dur... (PR Newswire)
12.10.21	CytoSorbents Provides Preliminary Third Quarter Business Update and Revised 2021 Product Revenue Guidance (PR Newswire)
07.10.21	CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference (PR Newswire)
14.09.21	CytoSorbents to Host International Webinar on the Worldwide Experience Using CytoSorb® in Critically Ill Patients with COVID-19 (PR Newswire)
13.09.21	CytoSorbents Commemorates World Sepsis Day and Sepsis Awareness Month with Key Sepsis-Related Events, Sponsorships and Studies (PR Newswire)
10.09.21	CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ Antithrombotic Removal System During... (PR Newswire)
08.09.21	CytoSorbents Announces Webinar Discussing Topline Results from the U.S. CTC Registry using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) (PR Newswire)
01.09.21	U.S. CTC Registry Shows High Survival Using CytoSorb In Critically Ill COVID-19 Patients On ECMO (RTTNews)
01.09.21	Topline Results from CytoSorbents' U.S. CTC Multicenter Registry Demonstrate High Survival using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) (PR Newswire)
30.08.21	CytoSorbents and Aferetica Announce the Commercial Launch in Italy of the PerSorb™ Adsorber and PerLife™ Organ Perfusion System, respectively, at the European Society of Organ Transplantation Congress (PR Newswire)
12.08.21	Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR™ Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent C... (PR Newswire)
03.08.21	CytoSorbents Reports Second Quarter 2021 Financial and Operational Results (PR Newswire)
30.07.21	CytoSorbents Completes its Mission 100,000 International Fundraising Campaign to Fight the Spread of COVID-19 for Global Humanitarian Organization, CARE (PR Newswire)
19.07.21	CytoSorbents to Report Second Quarter 2021 Operating and Financial Results (PR Newswire)
06.07.21	CytoSorbents Receives Full FDA Approval of Investigational Device Exemption (IDE) for U.S. STAR-T Trial on Ticagrelor Removal During Cardiothoracic Surgery (PR Newswire)
04.01.21	CytoSorbents : Health Canada Okays CytoSorb For Use In Hospitalized COVID-19 Patients (RTTNews)
22.07.20	Stock Alert: Cytosorbents Corporation Spikes 10% (RTTNews)
13.04.20	Stock Alert: CytoSorbents Up 30% On FDA's Approval To Use CytoSorb For COVID-19 (RTTNews)
13.04.20	CytoSorbents: FDA Grants EUA Of CytoSorb In Patients With COVID-19 Infection (RTTNews)
25.03.20	Stock Alert: Cytosorbents Shares Up 36% In Pre-Market (RTTNews)
02.03.20	Stock Alert: Cytosorbents Corp. (CTSO) (RTTNews)
12.06.18	CytoSorbents Officially Opens New U.S. CytoSorb Manufacturing Facility (PR Newswire)
04.06.18	CytoSorbents to Present at the Jefferies 2018 Global Healthcare Conference (PR Newswire)
21.05.18	CytoSorbents to Present at the 19th Annual B. Riley FBR Investor Conference (PR Newswire)
14.05.18	CytoSorb® Adds Bilirubin and Myoglobin Reduction to European Union Approved Indications for Use (PR Newswire)
08.05.18	CytoSorbents Reports Strong First Quarter 2018 Financial Results (PR Newswire)
02.05.18	CytoSorbents to Report Q1 2018 Operating and Financial Results (PR Newswire)
01.05.18	OppenheimerFunds Announces Factor Derby for Charity (PR Newswire)
26.04.18	CheapOair.com Shares Top Hacks for Finding Cheap Airfare (PR Newswire)
24.04.18	CytoSorbents Enrolls First Patient into Pivotal U.S. REFRESH 2-AKI Trial Using CytoSorb® During Complex Cardiac Surgery (PR Newswire)
09.04.18	CytoSorbents to Meet With European Investors at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo and in Meetings in Frankfurt, Geneva and Zurich (PR Newswire)
06.04.18	BLANCO launches the innovative PRECISION® R0 Farmhouse sink crafted of its groundbreaking DURINOX® material (PR Newswire)
04.04.18	CytoSorbents Refinances Existing Debt with New $15 Million Debt Facility with Bridge Bank (PR Newswire)
28.03.18	CytoSorbents Reports on the Successful 5th International CytoSorb Users Meeting and 38th ISICEM Critical Care Conference (PR Newswire)
12.03.18	CytoSorbents to Present at the 38th Annual Cowen Healthcare Conference (PR Newswire)
08.03.18	CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017 (PR Newswire)
01.03.18	CytoSorbents to Report Fiscal 2017 Operating and Financial Results (PR Newswire)
26.02.18	CytoSorbents to Participate at the BTIG Healthcare Conference (PR Newswire)
15.02.18	CytoSorbents Expands Its Partnership with Biocon to Launch CytoSorb® in Malaysia (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Cytosorbents Corp

Aktien Top/Flop

Meistgelesene Nachrichten